INTRODUCTION

CD4
+ T helper (Th) cells are central in orchestrating adaptive immune responses; distinct Th cell subsets are involved in protective immune responses to a variety of pathogens (Kanno et al., 2012; Zhu et al., 2010) . For example, type 1 T helper (Th1) cells are critical for eradicating intracellular bacteria and viruses, whereas type 2 Th (Th2) cells are indispensable for the expulsion of helminths. Interleukin-17 (IL-17)-producing Th cells (also known as Th17 cells) are critical for defending against extracellular bacterial and fungal infections. It usually takes several (5-10) days for antigen-specific CD4 + T cells to expand from rare precursors in the naive population and reach a meaningful number to execute host defense functions. Therefore, many innate effector cells, including natural killer (NK) cells, are responsible for early control of invading pathogens. Recently, a new class of innate effector cells whose development relies on signaling through the IL-2 receptor (IL-2R) common g chain and IL-7Ra has drawn much attention. These cells, together with classical NK cells, are often referred to as innate lymphoid cells (ILCs) (Sonnenberg and Artis, 2012; Spits and Cupedo, 2012; Spits and Di Santo, 2011) . Because distinct subsets of ILCs are capable of making the same characteristic effector cytokines as produced by different Th cell subsets, they are similarly classified into type 1 ILCs (ILC1s), including classical NK cells that produce interferon-g (IFN-g), type 2 ILCs (ILC2s), which produce IL-5 and IL-13, and type 3 ILCs (ILC3s), including lymphoid tissue inducer (LTi) cells, which produce IL-17 and IL-22 (Spits et al., 2013; Walker et al., 2013) . By producing Th2 cell effector cytokines such as IL-13, ILC2s play an important role during early immune responses to helminth infection (Fallon et al., 2006; Moro et al., 2010; Neill et al., 2010; Price et al., 2010; Saenz et al., 2010) . Mice with dysfunctional ILC2s have a significant delay in worm expulsion in Nippostrongylus brasiliensis infection, whereas expanding the number of ILC2s by IL-25 injection can eliminate the need for Th2 cells in effective resistance to helminth infection. ILC2s are also important for allergen-induced airway inflammation and lung-tissue repair in animal models (Chang et al., 2011; Halim et al., 2012a; Monticelli et al., 2011) , and human cells corresponding to the ILC2s found in mice have been identified (Mjö sberg et al., 2011) . The ILCs that produce IL-17 and IL-22 also participate in the early phase of responses to infections and in inflammatory disorders (Buonocore et al., 2010; Lee et al., 2012; Powell et al., 2012; Satoh-Takayama et al., 2008) . Thus, understanding the molecular mechanisms controlling the development and functions of ILCs is essential to developing strategies to control responses to pathogens and autoimmunity.
GATA3 is the key transcription factor for Th2 cell differentiation . GATA3 expression is indispensable for proper induction of Th2 cytokines, including IL-4, IL-5, and IL-13, both in vitro and in vivo (Zhu et al., 2004) . Interestingly, GATA3 is critical not only for regulating Th2 cell differentiation but also for CD4 + T cell development in the thymus at multiple stages (Ho et al., 2009; Pai et al., 2003; Ting et al., 1996) .
It has been reported that GATA3 is highly expressed by ILC2 cells (Moro et al., 2010; Price et al., 2010) . Conditional inactivation of Gata3 with a transgenic Cre whose expression is driven by the Il13 locus completely eliminated IL-13-producing ILC2 cells (Liang et al., 2012) . GATA3 has been shown to be critical for the maintenance of ILC2 number and IL-13 production by these cells both in mice and in humans (Furusawa et al., 2013; Hoyler et al., 2012; Klein Wolterink et al., 2013; Mjö sberg et al., 2012; Yang et al., 2013) . However, because GATA3 affects ILC2 number, IL-13 regulation by GATA3 in the previous studies requires more careful assessment, i.e., at a single-cell level with proper controls. Furthermore, other important target genes that are regulated by GATA3 in ILC2s are largely unknown. Finally, whether other ILC subsets require GATA3 to develop remains unclear.
Here, we report that GATA3 is not only critical for T cell development but also Figure S1A , available online). Some of these ILCs were ILC2s, identified by expression of T1/ST2 (IL-33R) (Moro et al., 2010; Neill et al., 2010 Figure S1C ). Thus, all IL-7Ra ILCs expressed GATA3, albeit at different amounts.
GATA3 Is Indispensable for the Development of All IL7Ra + ILCs
To study the role of GATA3 in ILC development in vivo, we generated Gata3 fl/fl -Vav-Cre mice in which Gata3 exon 4 was deleted in hematopoietic stem cells. As expected, no T cells were detected in Gata3 fl/fl -Vav-Cre mice ( Figure 1A ), confirming a previous report on the critical role of GATA3 in T cell development as determined by germline Gata3 deletion (Ting et al., 1996) . In contrast, there was a modest but significant increase in B cells in Gata3 fl/fl -Vav-Cre mice ( Figure 1A ), arguing against a loss of stem cell function. In line with a previous report showing that GATA3 is critical for the development of IL-7Ra + NK cells (Vosshenrich et al., 2006) were not significantly affected ( Figure 1A ). Staining of cells from the lung of Gata3 fl/fl -Vav-Cre mice showed complete absence of ILC2s ( Figure 1B ). In the bone marrow of wild-type mice, T1/ST2 + cells were detectable among the Lin À CD127 + population; these cells have been regarded as the progenitors of ILC2s and they were all GATA3 + ( Figure 1C ). However, this population was absent in the bone marrow of Gata3 fl/fl -Vav-Cre mice ( Figure 1C ). Overall, our data indicate that GATA3 is indispensable for the development of ILC2s and T cells, but not B cells or IL-7Ra À NK cells.
We also noticed a defect in lymphoid organ development in the Gata3 fl/fl -Vav-Cre mice; similar to RORgt-deficient mice, these mice had no lymph nodes, including the brachial and axillary lymph nodes. This finding suggests that GATA3 regulates the development of LTi cells, which are Lin À CD4 + RORgt + and critical for the development of lymph node structure (Eberl et al., 2004; Sun et al., 2000) . Indeed, Lin Figure S2 ).
LTi progenitors have been identified in the mouse fetal liver (Cherrier et al., 2012; Possot et al., 2011 Figure 3D ). These data further establish the role of GATA3 in the development of IL-22-producing ILCs.
The Effect of GATA3 on the Development of IL-7Ra + ILCs
Is Cell Intrinsic Vav-Cre deletes floxed genes specifically in hematopoietic stem cells; therefore, the failure of ILC development in Gata3 fl/fl -VavCre mice is not due to a GATA3 function in nonhematopoietic cells. To further confirm this, we performed mixed bone marrow chimera experiments to directly examine whether the influence of GATA3 on ILC development is cell intrinsic. As expected, GATA3-sufficient and -deficient bone marrow cells efficiently repopulated CD45 + cells in the spleen of Rag2 Figure 4 ). However, GATA3-deficient bone marrow cells failed to give rise to IL-7Ra + ILCs in the mixed bone marrow chimeras. In contrast, B cells developed normally, whereas T cells failed to develop from GATA3-deficient bone marrow progenitors. These results indicate that the effect of GATA3 on the development of IL-7Ra + ILCs is cell intrinsic.
GATA3 Is Required for Maintaining ILC2 Number Both In Vivo and In Vitro
At first consideration, our results contradict an earlier report showing that GATA3 is required for the development of ILC2s, but not other ILCs (Hoyler et al., 2012) . However, in that study, Gata3 was deleted by an inducible Cre driven by the Id2 locus after all the ILCs had fully developed. Therefore, it is likely that the survival of ILC2s is sensitive to Gata3 deletion. To test this possibility, we generated Gata3 fl/fl -CreER T2 mice and treated them with tamoxifen. Three weeks after treatment, we observed that only KLRG1 + ILC2s, but not RORgt + ILCs, in the siLP were diminished ( Figure 5A ), confirming that GATA3 is critical only for the maintenance of ILC2s in vivo. Because GATA3 is required for the development and maintenance of ILC2s in vivo, it is difficult to assess the function of GATA3 in ILC2s without obtaining a pure ILC2 population. ILC2s, although present at a low frequency, expand during type 2 immune responses, presumably as a result of stimulation by IL-25 and/or IL-33, which are produced by epithelial cells. Indeed, injection of IL-25 induced substantial expansion of ILC2s (Neill et al., 2010; Saenz et al., 2013) . We also observed that IL-25 injection induced the expansion of ILC2s. Culturing sorted Lin À cells harvested from mesenteric lymph nodes of IL-25-injected mice with IL-33, IL-25, and IL-7 in vitro further expanded these cells. After 5-7 days of culture of purified Lin À cells, virtually all cells were GATA3 hi ( Figure S3A ). These cells also expressed two cell-surface molecules, Sca-1 and KLRG1, which are highly expressed by ILC2s ( Figures S3B and S3C ). Therefore, we chose this approach in an effort to obtain large numbers of ILC2s at high purity; staining and/or sorting for T1/ST2-and IL-7Ra-expressing cells was not required until the end of the culture, alleviating the concern that antibody staining might affect IL-33 or IL-7 signaling.
To determine the function of GATA3 in ILC2s, we prepared ILC2s, as described in Figure S3 , from Gata3
Gata3 fl/fl mice. After 5 days of culture, samples were split into two groups and treated either with 4-hydroxytamoxifen (4-OHT), the active metabolite of tamoxifen that binds to CreER T2 to induce
Cre activity, or with a vehicle control, ethanol (EtOH). To test whether GATA3 affects ILC2 maintenance in culture in a cellintrinsic manner, we mixed Gata3
with ILC2s generated from CD45.1 congenic mice. After 4-OHT treatment, there was a progressive decrease in the percentage of Gata3-deficient ILC2s over a 6-day period ( Figure 5B ). To comprehensively profile the genes regulated by GATA3 in ILC2s at a genome-wide level, we sorted live ILC2s that had or had not undergone Gata3 inactivation on day 2, a time point when no dramatic ILC2 loss was observed, and performed RNA sequencing (RNA-seq) analyses. Interestingly, we found that many TNF and TNFR superfamily genes, such as Tnfrsf9 (encoding 4-1BB, which provides costimulation) and Tnfsf21 (encoding DR6, which induces cell apoptosis), and NF K b family members, including Nfkb2 and Relb, showed altered expression patterns ( Figure 5C ). In addition, the cell-cycle inhibitor Cdkn2b was upregulated upon Gata3 inactivation ( Figure 5C ). These changes are consistent with and might contribute to the loss of Gata3-deficient ILC2s.
GATA3 Regulates Many Critical Genes in ILC2s and Th2
Cells RNA-seq results confirmed efficient Gata3 inactivation by Cre-ER T2 after 4-OHT treatment given that a nearly 100% reduction of the reads at Gata3 exon 4 was observed ( Figure 6A ). Interestingly, reads at the other exons of Gata3 were only modestly affected, implying that GATA3 is not a major player in maintaining its own transcription in ILC2s ( Figure 6A ). We then compared genes that are either positively or negatively regulated by GATA3 in ILC2s and Th2 cells (Wei et al., 2011) . A total of 32 genes that are positively regulated by GATA3 in Th2 cells were also affected in ILC2s upon Gata3 inactivation ( Figures 6B and 6C and Table S1 ). Il13 transcripts were dramatically reduced when GATA3 was absent in ILC2s (Figure 6C and Table S1 ). Other genes that are positively regulated by GATA3 in both ILC2s and Th2 cells include Areg (encoding Amphiregulin), Il5, Ccr8, and Lif ( Figure 6C and Table S1 ). Interestingly, Il1rl1 (encoding IL-33R) and Il9r were expressed at much higher levels in ILC2s than in Th2 cells; their expression was dramatically reduced when Gata3 was disrupted in ILC2s ( Figure 6C and Table S1 ).
We also identified 225 genes, including Il4, Maf, Pth, and Ikzf3 (encoding Aiolos), that are positively regulated by GATA3 in Th2 cells but that are not affected by GATA3 in ILC2s ( Figure 6B ). On the other hand, 130 genes are positively regulated by GATA3 in ILC2s, but not in Th2 cells; they include Icos, Il2ra, Kit, Il1r2, Cysltr1, Htr1b, and Tph1, many of which are cell-surface markers of ILC2s (Figures 6B and 6D and Table S1 ). These data indicate that GATA3 has unique functions in ILC2s and Th2 cells in addition to its common regulation of many type 2 effector cytokines.
Gata3 inactivation in Th2 cells resulted in derepression of several Th1-cell-associated genes, such as Fasl, Il12rb2, and Stat4 (Table S1 ). However, Gata3 inactivation in ILC2s did not alter the expression of these genes; instead, it derepressed several other genes-such as Cd244 (encoding 2B4), Lta, and Tnf ( Figure 6E and Table S1)-that are characteristic of type I ILCs and/or NK cells.
Gata3 inactivation did not reduce Klrg1 transcription (Figure 6F) , suggesting that Klrg1 is not a GATA3 target gene. Other cell-surface molecules expressed by ILC2s include CD127, Sca-1, and Thy1. The expression of Il7r (encoding CD127) and Ly6a/e (encoding Sca-1) was reduced less than 2-fold, whereas Thy1 expression was increased upon Gata3 inactivation (Table  S1 ). The expression of Rora and Id2, encoding two transcription factors critical for the development of ILC2s, was not reduced upon Gata3 inactivation ( Figure 6F ).
To determine whether GATA3 has a similar function in ILC2s at the steady state, we performed RNA-seq by using ex-vivo-purified KLRG1 + ILC2s from tamoxifen-treated Gata3 fl/fl or Gata3 fl/flCre-ER T2 mice. The results indicated that among the 162 genes positively regulated by GATA3 in activated ILC2s, 57 genes were also positively regulated by GATA3 in ''naive'' ILC2s ( Figure 6G and Table S1 ). These included Il5, Il13, Areg, Il1r1, Ccr8, Il2ra, Cysltr1, Tph1, and Htr1b. Interestingly, Il10 and Il24 were regulated by GATA3 in activated ILC2s, but not in ''naive'' ILC2s ( Figure 6G ), suggesting that GATA3-mediated regulation of Il10 and Il24 expression requires cofactors that are only present in activated ILC2s. Il4 expression was affected by Gata3 deletion in ''naive'' ILC2s, but not in activated ILC2s ( Figure 6G ), consistent with our previous finding that GATA3 is required for the expression of IL-4 in developing Th2 cells but is not essential in fully differentiated Th2 cells. To verify the RNA-seq data at the protein level, we performed flow cytometry analysis. Compared to control samples, 4-OHTtreated Gata3 fl/fl -CreER T2 ILC2 culture showed no evidence of GATA3 expression, as judged by intracellular staining (Figure S4A) , implying that the deletion of Gata3 was efficient and the pre-existing GATA3 was degraded in ILC2s over a 2-day period. By contrast, consistent with the RNA-seq data, two cell-surface molecules highly expressed by ILC2s (KLRG1 and Sca-1) were only modestly, if at all, affected by inactivation of Gata3 ( Figures S4B and S4C ), demonstrating that ILC2s maintain some features of their phenotype in the absence of GATA3. Consistent with the role of GATA3 in Th2 cells, IL-13 production by ILC2s in response to IL-33 and IL-7 stimulation was dramatically reduced upon Gata3 inactivation ( Figure S4D ). In agreement with RNA-seq data, T1/ST2 surface expression was also abolished when Gata3 was inactivated in ILC2s ( Figure S4E ). This result raised the question of whether defective expression of IL-13 was due to a failure of the Gata3-deficient cells to respond to IL-33 or to a direct effect of GATA3 on Il13. Therefore, we stimulated these cells with PMA and ionomycin. Even with this potent stimulus, IL-13 production was dramatically decreased in Gata3-deficient cells ( Figure S4F ), suggesting that GATA3 directly regulates IL-13 production in ILC2s independently of its role in maintaining IL-33R expression. This is consistent Immunity GATA3 Regulates IL-7Ra-Expressing ILC Development with the established capacity of GATA3 to directly bind to the promoter of Il13 in many T cell subsets (Wei et al., 2011) .
GATA3 Regulates Common and Unique Sets of Genes in ILC2s and ILC3s
To determine the GATA3 target genes in ILC3s, we performed RNA-seq on ILC3s with or without Gata3 deletion. Ninety-eight and 81 genes were positively and negatively regulated, respectively, by GATA3 in ILC3s. Among the 98 positively regulated genes, 29 (including Atf3, Ccr9, Ets2, and Nr4a2) were also positively regulated by GATA3 in ILC2s ( Figure 7A and Table S1 ). Similarly, among the 81 negatively regulated genes, 17 were also negatively regulated by GATA3 in ILC2s. The functions of these 46 genes that were commonly regulated by GATA3 in ILC2s and ILC3s require further investigation. Many more genes are regulated by GATA3 in ILC2s than in ILC3s, possibly because GATA3 is expressed at much higher amounts in ILC2s than in ILC3s. Some cytokine-receptor-encoding genes regulated by GATA3 in ILC2s (such as Il1rl1, Il2ra, and Il9r) were not regulated by GATA3 in ILC3s. The expression of key transcription-factorencoding genes reported to be critical for the development of ILC3s, including Rorc, Runx1, Runx3, Ahr, Id2, and Tcf7, was not affected by Gata3 deletion in ILC3s ( Figure 7B ). Together with the finding that GATA3 does not affect the expression of Id2 and Rora in ILC2s ( Figure 6F ), our data indicate that the mechanism of GATA3 in regulating the development of IL7Ra-expressing ILCs is independent of, or in parallel with, all known key transcription factors.
DISCUSSION
Research on the ILCs has exploded since the description and characterization of the ILC2s in 2010 by four different groups (Moro et al., 2010; Neill et al., 2010; Price et al., 2010; Saenz et al., 2010) , and it is now well accepted that ILCs play important roles in innate immunity by producing effector cytokines (Spits et al., 2013) . Because these effector cytokines are virtually identical to those produced by Th cells, ILCs can be divided into ILC1s, ILC2s, and ILC3s, representing innate versions of Th1-, Th2-, and Th17-like cells, respectively (Spits et al., 2013) . There are also similarities in the development of ILCs and Th cells because the key transcription factor that determines a particular Th cell fate is also critically involved in the development of its ILC counterpart (Bernink et al., 2013; Eberl et al., 2004; Hoyler et al., 2012; Klose et al., 2013; Mjö sberg et al., 2012; Sciumé et al., 2012; Spits et al., 2013; Vonarbourg et al., 2010 Previous reports have suggested that ILC2s can be identified by a combination of several cell-surface markers, including T1/ ST2 (IL-33R), IL-25R, ICOS, Sca-1, and KLRG1, in addition to IL-2Ra and IL-7Ra (Halim et al., 2012b; Hoyler et al., 2012; Moro et al., 2010; Neill et al., 2010; Price et al., 2010; Saenz et al., 2010; Wong et al., 2012) . We have shown that GATA3 regulates most of these molecules. However, the expression of IL-7Ra and Sca-1 is only modestly reduced, and KLRG1 is not affected by Gata3 inactivation. We also identified other cell-surface molecules, including IL-9R, CCR8, cysteinyl leukotriene receptor 1 (Cysltr1), 5-hydroxytryptamine (serotonin) receptor 1B (Htr1b), and TNFR superfamily members 4-1BB and RANK, whose expression in ILC2s is GATA3 dependent, in addition to known ILC2 cell-surface markers. Cysltr1 is expressed by ILC2s, and leukotriene D 4 is able to induce the expression of IL-5, IL-13, and IL-4 (Doherty et al., 2013) . Therefore, GATA3 might indirectly affect type 2 cytokine production in vivo by regulating two stimulating receptors, T1/ST2 and Cysltr1. Overall, our data indicate that although GATA3 regulates many of the distinguishing cell-surface markers on ILC2s, other transcription factors are also involved. Identification of other factors that regulate KLRG1 expression might add important insights into the transcription factor networks controlling the development and maturation of ILC2s.
GATA3 plays critical roles in the differentiation and maintenance of both Th2 cells and ILC2s and thus is important for mediating type 2 immune responses at different stages. Through genome-wide profiling of the genes regulated by GATA3 in ILC2s, we found a substantial overlap of the genes regulated by GATA3 in Th2 cells and in ILC2s. Most strikingly, these commonly regulated genes included many key effector cytokines and receptors, such as Il13, Il5, Areg, Il10, Il24, Lif, Il1rl1, Il9r, and Ccr8 . Except for Il10 and Il24, which were expressed only in activated ILC2s, all other key cytokines and receptors were also regulated by GATA3 in ''naive'' ILC2s at the steady state. IL-4 was regulated by GATA3 in ''naive'' ILC2s, but not cultured ILC2s, consistent with our previous findings in T cells that GATA3 is important for the induction of IL-4 during Th2 cell differentiation but plays a minor role in IL-4 production in already developed Th2 cells. Thus, our data indicate that ILC2s resemble the innate counterpart of Th2 cells at a genomic scale and that GATA3 regulates the key functions shared by ILC2s and Th2 cells, possibly through a similar mechanism. GATA3 is thought to be critical for controlling the cell fate of ILC2s, but not other ILCs (Hoyler et al., 2012) . The discrepancy between this report and our study can be explained by the timing of Gata3 inactivation. In that study, Id2-driven Cre-ER T2 was used for conditional deletion of Gata3 by tamoxifen in otherwise normal mice. Because all the ILCs had already developed in these mice before Gata3 inactivation and the half-life of ILCs might be longer than 3 weeks, the specific effect on ILC2s 3 weeks after GATA3 removal only confirms that GATA3 is critical for the maintenance of ILC2s, but not other ILCs. Indeed, we were also able to show that tamoxifeninduced Gata3 deletion in Gata3 fl/fl -CreER T2 mice abolished ILC2s but had no effect on RORgt + ILCs once they had developed. Therefore, acute Gata3 ablation after ILCs have developed obscures the role we have revealed here for GATA3 during development of ILCs. Vav-Cre-mediated gene inactivation disrupted Gata3 before ILCs could develop, allowing us to conclude that GATA3 is critical for the development of all IL-7Ra + ILCs, including ILC2s.
All known subsets of ILCs and NK cells depend on Id2 expression for their development (Moro et al., 2010; Yokota et al., 1999) . Although E4BP4 (also known as NF-IL3) is critical for the development of NK cells (Gascoyne et al., 2009; Kamizono et al., 2009) , no severe ILC developmental defect has been reported in E4BP4-deficient mice. For the development of IL-7Ra + ILC subsets, RORa is a transcription factor specifically required for inducing ILC2s (Halim et al., 2012b; Wong et al., 2012) , but not RORgt-expressing ILCs (Halim et al., 2012b) . On the other hand, RORgt is only needed for the development of RORgt-expressing ILCs (Eberl et al., 2004; Halim et al., 2012b) , but not ILC2s (Halim et al., 2012b; Moro et al., 2010) . Up until now, the transcription factor critical for the development of all IL-7Ra + ILC lineages, but not NK cells, has not been identified. Here, we report that GATA3 is such a transcription factor. GATA3 does not seem to regulate Id2, RORa, or RORgt, suggesting that GATA3 might collaborate with Id2 for ILC development in general, with RORa for ILC2 development, and with RORgt for ILC3 development. Our data indicate that different IL-7Ra + ILC subsets might develop through a GATA3-dependent mechanism from a common progenitor. Thus, a hematopoietic branch point, with E4BP4 committing progenitors to the NK cell lineage and GATA3 leading to the development of IL-7Ra + ILCs, might exist. Our study shows that there is an excellent symmetry in ILC and Th cell development: although GATA3 is regarded as the master regulator for Th2 cells, it is also critical for the maintenance and functions of ILC2s, and although GATA3 is critical for the development of all CD4 + T cells (Ho et al., 2009) , it is also indispensable for the development of all IL-7Ra + ILC subsets. GATA3, therefore, plays parallel roles in establishing and regulating both adaptive and innate lymphocyte populations.
EXPERIMENTAL PROCEDURES Mice
Gata3
fl/fl mice on a C57BL/6 background were previously described (Yagi et al., 2010) . These mice were bred with either CreER T2 (Taconic line 10471) and the National Institute of Allergy and Infectious Diseases (NIAID). All mice were bred and/or maintained in the NIAID-specific pathogen-free animal facility, and the experiments were done when mice were 8 to 16 weeks of age under protocols approved by the NIAID Animal Care and Use Committee.
Citrobacter rodentium Infections
Citrobacter rodentium (formerly Citrobacter freundii, biotype 4280) strain DBS100 was prepared by selection of a single colony and culture in LuriaBertani broth for 8 hr. Mice were inoculated with approximately 1 3 10 10 colony-forming units (cfu) in 200 ml of PBS via oral gavage. Cells from the liLP were prepared as previously described (Sun et al., 2007) . cfu were determined via serial dilutions on MacConkey's agar from overnight cultures of homogenized fecal pellets.
Cell Preparation
Single-cell suspensions were prepared directly from mouse fetal livers or different lymphoid organs, including lymph nodes, spleen, and bone marrow. Cells from the siLP and IELs were prepared as previously described (Sun et al., 2007) . For preparing cells from tissues such as lung, mice were perfused with PBS before organs were harvested. The lung was cut into small pieces and digested with DNase I (Roche) and Liberase (Roche) for 30 min at 37 C.
Single-cell suspension from digested lung was subjected to Percoll density gradient centrifugation. In some experiments, recombinant murine IL-25 (from either eBioscience or PeproTech, 0.4 mg per mouse) in PBS was injected intraperitoneally into mice for 3 consecutive days before mesenteric lymph nodes were harvested. In other experiments, tamoxifen (Sigma) was intraperitoneally injected five times into mice every other day (5 mg tamoxifen in 150 ml corn oil per mouse per injection). In mixed bone marrow chimera experiments, bone marrow cells from Gata3 fl/fl or Gata3 fl/fl -Vav-Cre mice were mixed with bone marrow cells from CD45.1 congenic mice (line 7) at a 1:1 ratio and injected (10 million cells per mouse) into sublethally irradiated (450 Rad) Rag2
Il2rg
À/À mice (line 4111). Cells were stained with a cocktail of antibodies to various lineage markers, including antibodies to CD3, CD5, CD45R, CD11b, CD11c, NK1.1, Gr-1, TER119, FcεRI, and TCRg/d for identifying Lin À cells. Lin À cells were sorted with a FACS Aria and then cultured with IL-7 (10 ng/ml), IL-33 (10 ng/ml), and IL-25 (10 ng/ml) for $1 week. In some experiments, cells were treated with 100 nM 4-OHT after 5 days of culture for the deletion of Gata3 from Gata3 fl/fl -CreER T2 cells.
Flow Cytometry Analysis
Cell-surface molecule staining and cytokine intracellular staining were performed as previously described (Zhu et al., 2004) . Staining for transcription per group) were treated with tamoxifen in vivo for 2-3 days, and then ILC2s were sorted on the basis of KLRG1 expression. RNA-seq analyses were performed with Gata3-sufficent and Gata3-deficient cells. The Venn diagram shows the overlap of total genes positively regulated by GATA3 in cultured ILC2s and ILC2s at the steady state. Error bars represent the mean ± SD. See also Figure S4 and Table S1 .
factors was carried out with the Foxp3 Staining Buffer Set (eBioscience) according to the manufacturer's instructions. Flow cytometry data were collected with the LSR II (BD Biosciences), and the results were analyzed with FlowJo software (Tree Star). Antibodies specific to mouse CD5 (53-7.3), CD45R (RA3-6B2), Gr-1 (RB6-8C5), NK1.1 (PK136), and TCRg/d (UC7-13D5) and a mouse erythroid cell marker (TER119) were purchased from BioLegend; antibodies specific to mouse CD3 (2C11), CD4 (RM4-5), CD11b (M1/70), CD11c (N418), CD127 (A7R34), CD45.1 (A20), CD45.2 (104), FcεRI (MAR-1), IL-13 (eBio13A), KLRG1 (2F1), NKp46 (29A1.4), RORgt (AFKJS-9), Sca-1 (D7), Flt3 (A2F10), a4b7 (DATK32), and c-Kit (2B8) were purchased from eBiosciences; antibodies specific to Thy1.2 (53-2.1) and GATA3 (L50-823) were purchased from BD Biosciences; and antibodies specific to IL-33R (DJ8) were purchased from MD Bioproducts. RNA-seq experiments were performed. In brief, 100 ng of total RNA was amplified with the Ovation RNA-Seq System V2 (NuGEN). The resulting doublestranded DNA was sonicated to 200-400 bp. Two hundred fifty nanograms of sonicated DNA was used for preparing sequencing libraries for multiplex sequencing (Illumina), and 50 bp reads were generated by the NHLBI DNA Sequencing and Computational Biology Core. Sequencing reads were mapped to the mm9 genome (UCSC Genome Browser). Gene expression levels were measured by RPKM (reads per kilobase of exon per million reads) in the library (Mortazavi et al., 2008) . Differentially expressed genes were identified by edgeR (Robinson et al., 2010) with the following criteria: false discovery rate < 0.001, fold change > 2, and RPKM > 3 in either Gata3-sufficient or -deficient samples.
RNA-Seq and Data Analysis
ACCESSION NUMBERS
RNA-seq data are available in the Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/gds) under the accession number GSE47851. sorted. RNA-seq analyses were performed with Gata3-sufficent and Gata3-deficient ILC3s. RNA-seq analyses were also performed with Gata3-sufficent and Gata3-deficient ILC2s, as described in Figure 6G . The Venn diagram shows the overlap of total genes positively or negatively regulated by GATA3 in ILC2s and ILC3s.
SUPPLEMENTAL INFORMATION
(B) Expression of Rorc, Runx1, Runx3, Id2, Ahr, and Tcf7 was not affected by Gata3 inactivation in ILC3s. Error bars represent the mean ± SD.
